Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2025 Mar 4;46(3):489-494.
doi: 10.3174/ajnr.A8528.

Black Hole Sign under Anticoagulant Therapy: A Retrospective Comparison of Warfarin and Direct Oral Anticoagulants

Affiliations
Comparative Study

Black Hole Sign under Anticoagulant Therapy: A Retrospective Comparison of Warfarin and Direct Oral Anticoagulants

Hirotaka Sato et al. AJNR Am J Neuroradiol. .

Abstract

Background and purpose: Direct oral anticoagulants (DOAC) have rapidly replaced warfarin. Intracerebral hemorrhage (ICH) is known to be one of the most severe side effects of anticoagulant drugs. The black hole (BH) sign is reportedly a valid radiologic sign for predicting hematoma expansion in acute ICH. Here, we hypothesized that the frequency of BH signs might differ between warfarin and DOAC treatment. We critically evaluated the clinical value of the BH sign in acute ICH under warfarin versus DOAC therapy.

Materials and methods: Patients with acute ICH under anticoagulant therapy were enrolled. Hematoma volumes were measured by ABC/2. Radiologists blinded to the clinical information determined the presence or absence of the BH sign on CT images. This study defined a more than 12.5 mL increase in hematoma volume as cases with "expanded hematoma."

Results: We analyzed 111 patients with acute ICH under anticoagulant therapy. Among them, 21 patients were treated with antagonists in this cohort. Multivariate logistic regression analysis revealed that the presence of ventricular perforation (P = .02; adjusted OR: 3.51; 95% CI: 1.32-10.2) and the BH sign (P < .01; adjusted OR: 4.86; 95% CI: 1.73-14.3) were significantly different between expanded and nonexpanded hematoma cases. Comparison of hematoma volume and the presence of the BH sign between warfarin and DOAC cases indicated significant differences in maximum hematoma volume (P = .03) and presence of the BH sign (P < .01). The increase in hematoma volume was significantly greater when the BH sign was present under warfarin therapy (P = .05). In contrast, the increase in hematoma volume did not differ between cases with and without the BH sign in patients under DOAC therapy (P = .14).

Conclusions: The BH sign is a useful radiologic signature to predict the expansion of acute ICH under anticoagulant therapy. ICH under warfarin tended to present the BH sign more frequently than that under DOAC. The results also showed that the BH sign is more reliable under warfarin than under DOAC therapy in patients with ICH.

PubMed Disclaimer

References

    1. Chan NC, Paikin JS, Hirsh J, et al. . New oral anticoagulants for stroke prevention in atrial fibrillation: impact of study design, double counting and unexpected findings on interpretation of study results and conclusions. Thromb Haemost 2014;111:798–807 10.1160/TH13-11-0918 - DOI - PubMed
    1. Dowlatshahi D, Butcher KS, Asdaghi N; Canadian PCC Registry (CanPro) Investigators, et al.. Poor prognosis in warfarin-associated intracranial hemorrhage despite anticoagulation reversal. Stroke 2012;43:1812–17 10.1161/STROKEAHA.112.652065 - DOI - PubMed
    1. Kurogi R, Nishimura K, Nakai M; J-ASPECT Study Collaborators, et al.. Comparing intracerebral hemorrhages associated with direct oral anticoagulants or warfarin. Neurology 2018;90:e1143–e1149 10.1212/WNL.0000000000005207 - DOI - PMC - PubMed
    1. Brouwers HB, Greenberg SM. Hematoma expansion following acute intracerebral hemorrhage. Cerebrovasc Dis 2013;35:195–201 10.1159/000346599 - DOI - PMC - PubMed
    1. Li Q, Zhang G, Xiong X, et al. . Black hole sign: novel imaging marker that predicts hematoma growth in patients with intracerebral hemorrhage. Stroke 2016;47:1777–81 10.1161/STROKEAHA.116.013186 - DOI - PubMed

Publication types